NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

日光角化症治療的全球市場(2020年∼2026年)

Global Actinic Keratosis Treatment Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 986553
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
日光角化症治療的全球市場(2020年∼2026年) Global Actinic Keratosis Treatment Market 2020-2026
出版日期: 2020年11月18日內容資訊: 英文
簡介

在預測期內,光化性角化病治療的市場規模預計將顯示出顯著增長。隨著治療光化性角化病的新方法的不斷發展,光化性角化病的流行率和發病率的上升預計將成為促進市場增長的重要因素。

這份報告提供日光角化症治療的世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,類型·終端用戶·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢
  • 法律規章

第3章 競爭情形

  • 企業佔有率分析
  • 重要的策略分析
  • 主要企業分析
    • LEO Pharma A/S
    • Biofrontera AG
    • Sun Pharmaceuticals Industries, Ltd.
    • 3M Co.
    • Galderma S.A.

第4章 市場決策要素

  • 動機
  • 阻礙因素
  • 市場機會

第5章 市場細分化

  • 各類型
    • 投藥
    • 治療
    • 其他(聯合治療)
  • 各終端用戶
    • 醫院及腫瘤學中心
    • 皮膚科診所

第6章 各地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • 3M Co.
  • Alma Lasers, Inc.
  • Almirall, S.A.
  • Bausch Health Companies Inc.
  • Biofrontera AG
  • BioLineRx, Ltd.
  • Cipher Pharmaceuticals, Inc.
  • Galderma S.A.
  • Hill Dermaceuticals, Inc.
  • LEO Pharma A/S
  • Mylan N.V.
  • Stanford Chemicals Company
  • Sun Pharmaceutical Industries, Ltd.
  • Teva Pharmaceutical Industries, Ltd.
  • Valeant Pharmaceuticals, Inc.
目錄
Product Code: OMR2022902

Global Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report by Type (Medication, Therapy, and Other), and By End-User (Hospitals & Oncology Centers, and Dermatology Clinics) Forecast period (2020-2026)

The actinic keratosis treatment market is anticipated to showcase a considerable growth rate during the forecast period. The rising prevalence and incidence of actinic keratosis treatment along with the rising development of novel approaches for the treatment of actinic keratosis is anticipated to be a key factor contributing to the growth of the market.

The actinic keratosis treatment market is segmented based on type, and end-user. Based on the type, the market is segmented into medication, therapy, and other (combination therapy). Medication to showcase considerable growth based on treatment type. The growing FDA approval for the new drugs to treat actinic keratosis is anticipated to drive the growth of this market segment. Based on medication, the market is segmented into fluorouracil, imiquimod, ingenol mebutate, others. Based on therapy, the market is segmented into photodynamic therapy and LASER surgery. Based on end-user, the market is segmented into hospitals & oncology centers, and dermatology clinics.

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is anticipated to hold a considerable market share in the actinic keratosis treatment market due to the high awareness of the drugs for the treatment of actinic keratosis treatment in the region. Asia-Pacific is the fastest-growing region in the market. The increasing prevalence of skin disorders in the emerging economies of Asia-Pacific is a key factor contributing to the growth of the market in the region.

The key players in the actinic keratosis treatment market include Bausch Health Companies, Inc., Biofrontera AG, BioLineRx, Ltd., Cipher Pharmaceuticals, Inc., Galderma SA, Hill Dermaceuticals, Inc., LEO Pharma A/S, Valeant Pharmaceuticals Inc., and so on. The major players of the market are making hefty investments in the R&D of new drugs and therapies. The continuous efforts of the market players in the development of new drugs and therapies are driving the growth of the global market.

Research Methodology

The market study of the global actinic keratosis treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Actinic Keratosis Treatment Market Research and Analysis by Type

2. Global Actinic Keratosis Treatment Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global actinic keratosis treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global actinic keratosis treatment market.
  • Insights about market determinants that are stimulating the global actinic keratosis treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. LEO Pharma A/S
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Biofrontera AG
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Sun Pharmaceuticals Industries, Ltd.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. 3M Co.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Galderma S.A.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Actinic Keratosis Treatment Market by Type
    • 5.1.1. Medication
      • 5.1.1.1. Fluorouracil
      • 5.1.1.2. Imiquimod
      • 5.1.1.3. Ingenol Mebutate
      • 5.1.1.4. Others
    • 5.1.2. Therapy
      • 5.1.2.1. Photodynamic Therapy
      • 5.1.2.2. Laser Surgery
    • 5.1.3. Others (Combination Therapy)
  • 5.2. Global Actinic Keratosis Treatment Market by End-User
    • 5.2.1. Hospitals & Oncology Centers
    • 5.2.2. Dermatology Clinics

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. 3M Co.
  • 7.2. Alma Lasers, Inc.
  • 7.3. Almirall, S.A.
  • 7.4. Bausch Health Companies Inc.
  • 7.5. Biofrontera AG
  • 7.6. BioLineRx, Ltd.
  • 7.7. Cipher Pharmaceuticals, Inc.
  • 7.8. Galderma S.A.
  • 7.9. Hill Dermaceuticals, Inc.
  • 7.10. LEO Pharma A/S
  • 7.11. Mylan N.V.
  • 7.12. Stanford Chemicals Company
  • 7.13. Sun Pharmaceutical Industries, Ltd.
  • 7.14. Teva Pharmaceutical Industries, Ltd.
  • 7.15. Valeant Pharmaceuticals, Inc.

LIST OF TABLES

  • 1. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL MEDICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 5. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 6. GLOBAL HOSPITALS & ONCOLOGY CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL DERMATOLOGY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 8. NORTH AMERICAN ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 9. NORTH AMERICAN ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 10. NORTH AMERICAN ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 11. EUROPEAN ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 12. EUROPEAN ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 13. EUROPEAN ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 14. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 15. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 16. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 17. REST OF THE WORLD ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 18. REST OF THE WORLD ACTINIC KERATOSIS TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SHARE BY END-USER, 2019 VS 2026 (%)
  • 3. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. THE US ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. ROE ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)

16. REST OF THE WORLD ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)